estrogen receptor antagonist and degrader
This page covers all estrogen receptor antagonist and degrader drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting estrogen receptor.
Targets
Marketed (1)
- Palazestrant · Pfizer Inc. · Oncology